Market Overview

UPDATE: Jefferies & Company Reiterates Hold Rating, Raises PT on Xilinx

Related XLNX
Pepsi Beats; Positive Phase 3 Breast Cancer Data Creates Potential Buyout Target
Intuitive Surgical Rises On Upbeat Earnings; Xilinx Shares Slip

In a report published Friday, Jefferies & Company reiterated its Hold rating on Xilinx (NASDAQ: XLNX), and slightly raised its price target from $36.00 to $37.00.

Jefferies noted, “After Xilinx's CQ4 miss, we are incrementally more cautious on the stock, as we believe Moore Stress increases high-end FPGA vulnerability to disruption by mature node ASIC/ASSPs. We think the risk is higher in low-cost wireless base station for 3G/4G, which management appears optimistic would be a growth driver. We lower our estimates and reiterate our Hold rating.”

Xilinx closed on Thursday at $36.44.

Posted-In: Jefferies & CompanyAnalyst Color Price Target Analyst Ratings

 

Most Popular

Related Articles (XLNX)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free